Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Nanjing Legend Files for EU Approval of BCMA CAR-T

Nanjing Legend Biotech filed for EU approval of its BCMA CAR-T candidate in patients with multiple myeloma. In 2017, Legend stunned participants at the US ASCO meeting with the 94% complete remission rate of the CAR-T candidate. Later that year, Janssen Pharma, a division of Johnson and Johnson, paid $350 million upfront to partner the drug. Legend-Janssen is seeking European approval of ciltacabtagene autoleucel (cilta-cel) in patients with relapsed or refractory multiple myeloma, based on 95% overall response and 56% complete response in a Phase Ib/II study. More details.... Stock Symbol:  (NSDQ: LEGN) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.